Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 3rd Quarter - Report (No Activity)

CURE FORWARD

via GOLDBUG STRATEGIES LLC

3rd Quarter (July 1 - Sep 30) · 2016Posted Oct 20, 2016Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: CURE FORWARD
Description: Provides consumer genomic testing services
Location: Massachusetts · United States of America

Registrant

Firm: GOLDBUG STRATEGIES LLC
Description: Personal genomic services firm
Location: Rockville, Maryland, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

CURE FORWARD — Lobbying — Receipts Report